lysyl-lysyl-glycyl-glutamic acid has been researched along with glycylglutamine in 1 studies
| Studies (lysyl-lysyl-glycyl-glutamic acid) | Trials (lysyl-lysyl-glycyl-glutamic acid) | Recent Studies (post-2010) (lysyl-lysyl-glycyl-glutamic acid) | Studies (glycylglutamine) | Trials (glycylglutamine) | Recent Studies (post-2010) (glycylglutamine) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 104 | 8 | 14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ensor, DM; Miles, JB; Morley, JS; Owen, DL | 1 |
1 other study(ies) available for lysyl-lysyl-glycyl-glutamic acid and glycylglutamine
| Article | Year |
|---|---|
The C-terminal tetrapeptide of beta-endorphin (MPF) enhances lymphocyte proliferative responses.
Topics: Animals; beta-Endorphin; Cell Division; Concanavalin A; Dipeptides; Dose-Response Relationship, Immunologic; Endorphins; Enkephalin, Leucine; Enkephalin, Methionine; Glutamic Acid; Glycine; Humans; Lymphocyte Activation; Mitogens; Oligopeptides; Peptide Fragments; Rats; Species Specificity; T-Lymphocytes | 1998 |